Dimethyl Fumarate

tumor necrosis factor ; Homo sapiens







24 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34440900 Anti-Inflammatory and Anti-Oxidant Effect of Dimethyl Fumarate in Cystic Fibrosis Bronchial Epithelial Cells. 2021 Aug 19 1
2 34754326 Dimethyl Fumarate Ameliorates Nucleus Pulposus Cell Dysfunction through Activating the Nrf2/HO-1 Pathway in Intervertebral Disc Degeneration. 2021 1
3 32247228 Dimethyl fumarate promotes B cell-mediated anti-inflammatory cytokine profile in B and T cells, and inhibits immune cell migration in patients with MS. 2020 Jun 15 1
4 33003644 NRF2 and PPAR-γ Pathways in Oligodendrocyte Progenitors: Focus on ROS Protection, Mitochondrial Biogenesis and Promotion of Cell Differentiation. 2020 Sep 29 2
5 33087130 Dimethyl fumarate reduces TNF and Plasmodium falciparum induced brain endothelium activation in vitro. 2020 Oct 21 2
6 29800466 A randomized, subject and rater-blinded, placebo-controlled trial of dimethyl fumarate for obstructive sleep apnea. 2018 Aug 1 1
7 27974457 Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis. 2017 Jan 15 1
8 28732748 Controlling the pro-inflammatory function of 6-sulfo LacNAc (slan) dendritic cells with dimethylfumarate. 2017 Sep 1
9 26513635 Mutually enhancing anti-inflammatory activities of dimethyl fumarate and NF-κB inhibitors--implications for dose-sparing combination therapies. 2016 Feb 1
10 26246800 Dimethylfumarate protects against TNF-α-induced secretion of inflammatory cytokines in human endothelial cells. 2015 6
11 25009787 Dimethylfumarate attenuates restenosis after acute vascular injury by cell-specific and Nrf2-dependent mechanisms. 2014 3
12 25305493 Dimethyl fumarate protection against collagen II degradation. 2014 Nov 14 1
13 22790915 Dimethylfumarate inhibits CXCL10 via haem oxygenase-1 in airway smooth muscle. 2013 Jan 3
14 23567618 Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature. 2013 Jul 1
15 21414846 Fumaric acid and its esters: an emerging treatment for multiple sclerosis with antioxidative mechanism of action. 2012 Jan 4
16 21719482 IκBα glutathionylation and reduced histone H3 phosphorylation inhibit eotaxin and RANTES. 2011 Dec 2
17 21995308 Downregulation of endothelial adhesion molecules by dimethylfumarate, but not monomethylfumarate, and impairment of dynamic lymphocyte-endothelial cell interactions. 2011 Dec 1
18 20482831 Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1beta, TNF-alpha and IL-6 in an in-vitro model of brain inflammation. 2010 May 19 2
19 21136335 Inhibition of NF-κB and AP-1 by dimethylfumarate correlates with down-regulated IL-6 secretion and proliferation in human lung fibroblasts. 2010 4
20 19465513 Dimethylfumarate inhibits NF-{kappa}B function at multiple levels to limit airway smooth muscle cell cytokine secretion. 2009 Aug 3
21 19721818 Fumaric Acid and its esters: an emerging treatment for multiple sclerosis. 2009 Mar 4
22 17922812 Macrophage colony stimulating factor expression in human cardiac cells is upregulated by tumor necrosis factor-alpha via an NF-kappaB dependent mechanism. 2007 Dec 1
23 11971029 Dimethylfumarate inhibits TNF-induced nuclear entry of NF-kappa B/p65 in human endothelial cells. 2002 May 1 6
24 9168952 Dimethylfumarate is an inhibitor of cytokine-induced E-selectin, VCAM-1, and ICAM-1 expression in human endothelial cells. 1997 May 8 1